ADHDgene Database
  • Published Variant
  • Published Gene: 359
  • Published Region: 128
  • Pathway by PBA: 8
  • Study: 361

Literature Genes List

Search by: Type = Gene, Source = Literature-origin

Total result: 359

Approved Symbol Approved Name Location No. of Studies (significant/non-significant/trend)
ZNF805 zinc finger protein 805 19q13.43 1(0/0/1)
ZNF804A zinc finger protein 804A 2q32.1 2(0/2/0)
ZNF75A zinc finger protein 75a 16p13.11 1(0/0/1)
ZNF608 zinc finger protein 608 5q23.2 1(0/1/0)
ZNF544 zinc finger protein 544 19q13.43 1(0/0/1)
ZNF516 zinc finger protein 516 18q23 1(0/1/0)
ZNF423 zinc finger protein 423 16q12 1(0/0/1)
ZBBX zinc finger, B-box domain containing 3q26.1 1(0/0/1)
XPO1 exportin 1 2p15 1(0/0/1)
XKR4 XK, Kell blood group complex subunit-related family, member 4 8q12.1 1(1/0/0)
XKR3 XK, Kell blood group complex subunit-related family, member 3 22q11.1 1(0/0/1)
WDR96 WD repeat domain 96 10q25.1 1(0/0/1)
VEGFA vascular endothelial growth factor A 6p12 1(0/1/0)
VAMP2 vesicle-associated membrane protein 2 (synaptobrevin 2) 17p13.1 2(0/2/0)
USP24 ubiquitin specific peptidase 24 1p32.3 1(1/0/0)
UNC5B unc-5 homolog B (C. elegans) 10q22.2 1(0/0/1)
UGT1A9 UDP glucuronosyltransferase 1 family, polypeptide A9 2q37 1(0/0/1)
TSPAN8 tetraspanin 8 12q14.1-q21.1 1(0/1/0)
TRIO trio Rho guanine nucleotide exchange factor 5p14-p15.1 1(0/0/1)
TRIM32 tripartite motif containing 32 9q33.1 1(0/0/1)
TRANK1 tetratricopeptide repeat and ankyrin repeat containing 1 3p22.2 1(0/1/0)
TPH2 tryptophan hydroxylase 2 12q15 11(8/3/0)
TPH1 tryptophan hydroxylase 1 11p15.3-p14 6(2/4/0)
TNNI3K TNNI3 interacting kinase 1p31.1 1(0/1/0)
TMEM18 transmembrane protein 18 2p25.3 1(0/1/0)
TMEM160 transmembrane protein 160 19q13.32 1(0/1/0)
TMEM132B transmembrane protein 132B 12q24.31 1(0/1/0)
TLL2 tolloid-like 2 10q23-q24 1(0/0/1)
TLE4 transducin-like enhancer of split 4 (E(sp1) homolog, Drosophila) 9q21.32 1(1/0/0)
TLE1 transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila) 9q21.32 1(1/0/0)
TIAM2 T-cell lymphoma invasion and metastasis 2 6q25 1(0/0/1)
TH tyrosine hydroxylase 11p15.5 7(2/5/0)
TFEB transcription factor EB 6p21 1(0/0/1)
TFAP2B transcription factor AP-2 beta (activating enhancer binding protein 2 beta) 6p12 1(1/0/0)
TENM4 teneurin transmembrane protein 4 11q13 1(0/1/0)
TDP2 tyrosyl-DNA phosphodiesterase 2 6p22.3-p22.1 1(0/1/0)
TDO2 tryptophan 2,3-dioxygenase 4q31-q32 1(1/0/0)
TCERG1L transcription elongation regulator 1-like 10q26.3 1(0/0/1)
TCEB1 transcription elongation factor B (SIII), polypeptide 1 (15kDa, elongin C) 8q13.3 1(0/0/1)
TAF2 TAF2 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 150kDa 8q24 1(0/1/0)
TAAR3 trace amine associated receptor 3 (gene/pseudogene) 6q23-q24 1(0/1/0)
SYT2 synaptotagmin II 1q32.1 1(1/0/0)
SYT1 synaptotagmin I 12q21.2 4(2/2/0)
SYP synaptophysin Xp11.23-p11.22 4(4/0/0)
SYN3 synapsin III 22q12.3 2(1/1/0)
SUPT3H suppressor of Ty 3 homolog (S. cerevisiae) 6p21.1-p12.3 1(0/0/1)
STX1A syntaxin 1A (brain) 7q11.2 3(2/1/0)
STS steroid sulfatase (microsomal), isozyme S Xp22.32 3(2/1/0)
SSFA2 sperm specific antigen 2 2q32.1 1(0/1/0)
SRGAP1 SLIT-ROBO Rho GTPase activating protein 1 12q13.13 1(0/0/1)
SPOCK3 sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 4q32.3 1(1/0/0)
SORCS3 sortilin-related VPS10 domain containing receptor 3 10q23-q25 1(0/0/1)
SORCS1 sortilin-related VPS10 domain containing receptor 1 10q23-q25 1(0/0/1)
SNPH syntaphilin 20p13 1(1/0/0)
SNCA synuclein, alpha (non A4 component of amyloid precursor) 4q21.3-q22 1(0/1/0)
SNAP25 synaptosomal-associated protein, 25kDa 20p12-p11.2 21(16/5/0)
SLIT1 slit homolog 1 (Drosophila) 10q23.3-q24 1(0/0/1)
SLCO3A1 solute carrier organic anion transporter family, member 3A1 15q26 1(0/0/1)
SLC9A9 solute carrier family 9, subfamily A (NHE9, cation proton antiporter 9), member 9 3q23-q24 2(2/0/0)
SLC7A10 solute carrier family 7 (neutral amino acid transporter light chain, asc system), member 10 19q13.11 1(1/0/0)
SLC6A4 solute carrier family 6 (neurotransmitter transporter), member 4 17q11.2 26(13/13/0)
SLC6A3 solute carrier family 6 (neurotransmitter transporter), member 3 5p15.3 70(43/26/1)
SLC6A2 solute carrier family 6 (neurotransmitter transporter), member 2 16q12.2 16(10/5/1)
SLC6A1 solute carrier family 6 (neurotransmitter transporter), member 1 3p25.3 1(0/1/0)
SLC5A7 solute carrier family 5 (sodium/choline cotransporter), member 7 2q12 1(1/0/0)
SLC39A8 solute carrier family 39 (zinc transporter), member 8 4q22-q24 1(0/1/0)
SLC39A3 solute carrier family 39 (zinc transporter), member 3 19p13.3 1(0/1/0)
SLC38A1 solute carrier family 38, member 1 12q13.11 1(0/1/0)
SLC1A3 solute carrier family 1 (glial high affinity glutamate transporter), member 3 5p13 2(1/1/0)
SLC18A2 solute carrier family 18 (vesicular monoamine transporter), member 2 10q25 2(0/2/0)
SH3BP5 SH3-domain binding protein 5 (BTK-associated) 3p24.3 1(0/0/1)
SH2B1 SH2B adaptor protein 1 16p11.2 1(0/1/0)
SGTB small glutamine-rich tetratricopeptide repeat (TPR)-containing, beta 5q12.3 1(1/0/0)
SEC16B SEC16 homolog B (S. cerevisiae) 1q25.2 1(0/1/0)
SDK2 sidekick cell adhesion molecule 2 17q21.31 1(0/1/0)
RPL31P43 ribosomal protein L31 pseudogene 43 9q31.2 1(0/1/0)
RPL27A ribosomal protein L27a 11p15 1(0/1/0)
RPL23AP56 ribosomal protein L23a pseudogene 56 8q24.22 1(0/1/0)
RGS18 regulator of G-protein signaling 18 1q31.2 1(0/1/0)
REEP5 receptor accessory protein 5 5q22-q23 1(0/0/1)
RBMS3 RNA binding motif, single stranded interacting protein 3 3p24-p23 1(0/1/0)
RASSF2 Ras association (RalGDS/AF-6) domain family member 2 20p13 1(0/1/0)
QPCTL glutaminyl-peptide cyclotransferase-like 19q13.32 1(0/1/0)
PYDC2 pyrin domain containing 2 3q28 1(0/1/0)
PTPRN2 protein tyrosine phosphatase, receptor type, N polypeptide 2 7q36 1(0/0/1)
PTPRJ protein tyrosine phosphatase, receptor type, J 11p11.2 1(0/1/0)
PTPRG protein tyrosine phosphatase, receptor type, G 3p21-p14 1(0/0/1)
PTBP2 polypyrimidine tract binding protein 2 1p21.3 1(0/1/0)
PSMC3 proteasome (prosome, macropain) 26S subunit, ATPase, 3 11p11.2 1(0/0/1)
PRTG protogenin 15q21.3 1(1/0/0)
PRKG1 protein kinase, cGMP-dependent, type I 10q11.2 2(0/1/1)
PRKD1 protein kinase D1 14q11 1(0/1/0)
PRKAG2 protein kinase, AMP-activated, gamma 2 non-catalytic subunit 7q35-q36 1(0/0/1)
PRELID2 PRELI domain containing 2 5q32 1(0/1/0)
PPP2R2C protein phosphatase 2, regulatory subunit B, gamma 4p16.1 1(1/0/0)
PPP1R1B protein phosphatase 1, regulatory (inhibitor) subunit 1B 17q12 1(0/1/0)
PPM1H protein phosphatase, Mg2+/Mn2+ dependent, 1H 12q14.1 1(0/0/1)
PPM1F protein phosphatase, Mg2+/Mn2+ dependent, 1F 22q11.22 1(0/0/1)
POC5 POC5 centriolar protein 5q13.3 1(0/1/0)
PNMT phenylethanolamine N-methyltransferase 17q 3(2/1/0)
PLCL1 phospholipase C-like 1 2q33 1(0/0/1)
PHLDA1 pleckstrin homology-like domain, family A, member 1 12q15 1(0/1/0)
PGRMC2 progesterone receptor membrane component 2 4q26 1(0/1/0)
PEX5L peroxisomal biogenesis factor 5-like 3q27.1 1(0/0/1)
PER2 period circadian clock 2 2q37.3 1(1/0/0)
PER1 period circadian clock 1 17p13.1 1(0/1/0)
PCDP1 1(0/0/1)
PARK2 parkin RBR E3 ubiquitin protein ligase 6q25.2-q27 1(1/0/0)
OXTR oxytocin receptor 3p25 1(0/1/0)
OXER1 oxoeicosanoid (OXE) receptor 1 2p22.1 1(0/0/1)
OR4C3 olfactory receptor, family 4, subfamily C, member 3 11p11.2 1(0/0/1)
OPRM1 opioid receptor, mu 1 6q24-q25 1(1/0/0)
NYAP2 neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 2 2q36.3 1(0/1/0)
NXPH1 neurexophilin 1 7p22 1(0/1/0)
NUDT3 nudix (nucleoside diphosphate linked moiety X)-type motif 3 6p21.2 1(1/0/0)
NUCB1 nucleobindin 1 19q13.33 1(0/0/1)
NTRK2 neurotrophic tyrosine kinase, receptor, type 2 9q22.1 1(1/0/0)
NTM neurotrimin 11q25 1(0/1/0)
NTF3 neurotrophin 3 12p13 4(1/3/0)
NT5DC3 5'-nucleotidase domain containing 3 12q22-q23.1 1(0/0/1)
NT5C2 5'-nucleotidase, cytosolic II 10q24.32 1(1/0/0)
NRXN3 neurexin 3 14q31 1(0/1/0)
NRXN1 neurexin 1 2p16.3 1(0/1/0)
NRSN1 neurensin 1 6p22.1 1(1/0/0)
NR4A2 nuclear receptor subfamily 4, group A, member 2 2q22-q23 2(0/2/0)
NR3C2 nuclear receptor subfamily 3, group C, member 2 4q31 1(0/1/0)
NPSR1 neuropeptide S receptor 1 7p14.3 1(0/1/0)
NPPC natriuretic peptide C 2q37.1 1(0/1/0)
NPAS3 neuronal PAS domain protein 3 14q13.1 1(1/0/0)
NOS1 nitric oxide synthase 1 (neuronal) 12q24.22 1(1/0/0)
NLN neurolysin (metallopeptidase M3 family) 5q12.3 1(1/0/0)
NGF nerve growth factor (beta polypeptide) 1p13.1 2(2/0/0)
NFIL3 nuclear factor, interleukin 3 regulated 9q22 2(1/1/0)
NEUROD6 neuronal differentiation 6 7p15.1 1(0/1/0)
NET1 neuroepithelial cell transforming 1 10p15 1(1/0/0)
NEGR1 neuronal growth regulator 1 1p31.1 2(1/1/0)
NCKAP5 NCK-associated protein 5 2q21.2 1(0/0/1)
NCAN neurocan 19p12 1(0/1/0)
NAPRT1 nicotinate phosphoribosyltransferase domain containing 1 8q24.3 1(0/0/1)
NADSYN1 NAD synthetase 1 11q13.4 1(0/0/1)
MYT1L myelin transcription factor 1-like 2p25.3 1(0/0/1)
MYO5B myosin VB 18q 1(0/1/0)
MYBPC1 myosin binding protein C, slow type 12q23.2 1(0/1/0)
MTNR1B melatonin receptor 1B 11q21-q22 1(0/0/1)
MTNR1A melatonin receptor 1A 4q35 1(1/0/0)
MTIF3 mitochondrial translational initiation factor 3 13q12.2 1(1/0/0)
MTHFR methylenetetrahydrofolate reductase (NAD(P)H) 1p36.3 1(0/1/0)
MTCH2 mitochondrial carrier 2 11p11.2 1(0/1/0)
MOG myelin oligodendrocyte glycoprotein 6p22.1 1(0/1/0)
MOBP myelin-associated oligodendrocyte basic protein 3p21.33 1(0/0/1)
MMP7 matrix metallopeptidase 7 (matrilysin, uterine) 11q21-q22 1(0/0/1)
MMP24 matrix metallopeptidase 24 (membrane-inserted) 20q11.2 1(0/0/1)
MIR96 microRNA 96 7q32.2 1(1/0/0)
MEIS2 Meis homeobox 2 15q14 1(0/0/1)
MED27 mediator complex subunit 27 9q34.13 1(0/1/0)
MCTP1 multiple C2 domains, transmembrane 1 5q15 1(0/1/0)
MC4R melanocortin 4 receptor 18q22 1(0/1/0)
MAP2K5 mitogen-activated protein kinase kinase 5 15q22.31 1(1/0/0)
MAP2K3 mitogen-activated protein kinase kinase 3 17q11.2 1(0/1/0)
MAP1B microtubule-associated protein 1B 5q13 1(0/0/1)
MAOB monoamine oxidase B Xp11.4-p11.3 6(2/4/0)
MAOA monoamine oxidase A Xp11.4-p11.3 20(13/7/0)
MAN2A2 mannosidase, alpha, class 2A, member 2 15q25 1(0/0/1)
MAGI2 membrane associated guanylate kinase, WW and PDZ domain containing 2 7q21 1(0/0/1)
MAD1L1 MAD1 mitotic arrest deficient-like 1 (yeast) 7p22 1(0/1/0)
MACROD2 MACRO domain containing 2 20p12.1 1(0/0/1)
LRP1B low density lipoprotein receptor-related protein 1B 2q21.2 1(0/1/0)
LPL lipoprotein lipase 8p22 1(0/0/1)
LPHN3 latrophilin 3 4q13.1 4(3/0/1)
LOC643308 1(0/0/1)
LOC151121 1(0/1/0)
LOC100188947 1(1/0/0)
LOC100128765 1(0/0/1)
LMO4 LIM domain only 4 1p22.3 1(0/1/0)
LMAN2L lectin, mannose-binding 2-like 2q11.1 1(1/0/0)
LINGO2 leucine rich repeat and Ig domain containing 2 9p21.2 1(0/1/0)
LINC00478 long intergenic non-protein coding RNA 478 21q11-q21.1 1(0/0/1)
LIN7C lin-7 homolog C (C. elegans) 11p14 1(1/0/0)
LHFPL3 lipoma HMGIC fusion partner-like 3 7q22.2 1(1/0/0)
LECT1 leukocyte cell derived chemotaxin 1 13q14.3 1(0/1/0)
LARP7 La ribonucleoprotein domain family, member 7 4q25 1(1/0/0)
KIAA0319 KIAA0319 6p22.3 1(0/1/0)
KCTD15 potassium channel tetramerization domain containing 15 19q13.12 1(0/1/0)
KCNIP4 Kv channel interacting protein 4 4p15.32 1(1/0/0)
KCNC1 potassium voltage-gated channel, Shaw-related subfamily, member 1 11p15 1(0/1/0)
KANSL1 KAT8 regulatory NSL complex subunit 1 17q21.31 1(0/0/1)
KANK2 KN motif and ankyrin repeat domains 2 19p13.2 1(0/1/0)
ITIH3 inter-alpha-trypsin inhibitor heavy chain 3 3p21.1 1(1/0/0)
ITGAE integrin, alpha E (antigen CD103, human mucosal lymphocyte antigen 1; alpha polypeptide) 17p13 1(0/0/1)
ITGA11 integrin, alpha 11 15q22.3-q23 1(0/0/1)
ITGA1 integrin, alpha 1 5q11.1 2(0/2/0)
ISL1 ISL LIM homeobox 1 5q11.2 1(0/1/0)
IL20RA interleukin 20 receptor, alpha 6q23.3 1(0/0/1)
IL1RN interleukin 1 receptor antagonist 2q14.2 2(1/1/0)
IL16 interleukin 16 15q26.3 1(0/0/1)
ID2 inhibitor of DNA binding 2, dominant negative helix-loop-helix protein 2p25 1(0/1/0)
HTR7 5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled 10q21-q24 1(0/1/0)
HTR6 5-hydroxytryptamine (serotonin) receptor 6, G protein-coupled 1p36-p35 2(0/2/0)
HTR5A 5-hydroxytryptamine (serotonin) receptor 5A, G protein-coupled 7q36.1 1(0/1/0)
HTR4 5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled 5q31-q33 1(1/0/0)
HTR3B 5-hydroxytryptamine (serotonin) receptor 3B, ionotropic 11q23.1 3(1/2/0)
HTR3A 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic 11q23.1-q23.2 1(0/1/0)
HTR2C 5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled Xq23 5(2/3/0)
HTR2A 5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled 13q14-q21 13(7/6/0)
HTR1F 5-hydroxytryptamine (serotonin) receptor 1F, G protein-coupled 3p12 1(0/1/0)
HTR1E 5-hydroxytryptamine (serotonin) receptor 1E, G protein-coupled 6q14-q15 2(2/0/0)
HTR1D 5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled 1p36.3-p34.3 2(1/1/0)
HTR1B 5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled 6q13 14(5/9/0)
HTR1A 5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled 5q11.2-q13 2(2/0/0)
HOXB1 homeobox B1 17q21.32 1(0/0/1)
HLA-DRB1 major histocompatibility complex, class II, DR beta 1 6p21.3 2(1/1/0)
HKDC1 hexokinase domain containing 1 10q22.1 1(0/1/0)
HK1 hexokinase 1 10q22 1(0/1/0)
HES6 hes family bHLH transcription factor 6 2q37.3 1(0/1/0)
HES1 hes family bHLH transcription factor 1 3q28-q29 1(1/0/0)
HCN1 hyperpolarization activated cyclic nucleotide-gated potassium channel 1 5p12 1(0/1/0)
HAS3 hyaluronan synthase 3 16q22.1 1(0/0/1)
H2AFY H2A histone family, member Y 5q31.1 1(0/1/0)
GSK3B glycogen synthase kinase 3 beta 3q13.3 1(1/0/0)
GRM8 glutamate receptor, metabotropic 8 7q31.3-q32.1 1(1/0/0)
GRM7 glutamate receptor, metabotropic 7 3p26-p25 3(2/1/0)
GRM5 glutamate receptor, metabotropic 5 11q14.3 2(1/0/1)
GRM1 glutamate receptor, metabotropic 1 6q24 1(1/0/0)
GRIN2B glutamate receptor, ionotropic, N-methyl D-aspartate 2B 12p12 2(1/1/0)
GRIN2A glutamate receptor, ionotropic, N-methyl D-aspartate 2A 16p13.2 4(1/3/0)
GRIK4 glutamate receptor, ionotropic, kainate 4 11q23.3 1(0/1/0)
GRIK1 glutamate receptor, ionotropic, kainate 1 21q22 1(0/0/1)
GRID2 glutamate receptor, ionotropic, delta 2 4q22 1(0/0/1)
GPX6 glutathione peroxidase 6 (olfactory) 6p22.1 1(0/1/0)
GPRC5B G protein-coupled receptor, class C, group 5, member B 16p12 1(1/0/0)
GPR50 G protein-coupled receptor 50 Xq28 1(0/0/1)
GPR125 G protein-coupled receptor 125 4p15.31 1(0/1/0)
GPC6 glypican 6 13q32 1(0/0/1)
GPC5 glypican 5 13q32 1(0/0/1)
GNPDA2 glucosamine-6-phosphate deaminase 2 4p13 1(1/0/0)
GNAZ guanine nucleotide binding protein (G protein), alpha z polypeptide 22q11.1-q11.2 1(0/1/0)
GNAT2 guanine nucleotide binding protein (G protein), alpha transducing activity polypeptide 2 1p13 1(1/0/0)
GNAO1 guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O 16q13 1(0/1/0)
GNAL guanine nucleotide binding protein (G protein), alpha activating activity polypeptide, olfactory type 18p11.22-p11.21 1(1/0/0)
GIT1 G protein-coupled receptor kinase interacting ArfGAP 1 17p11.2 2(1/1/0)
GFOD1 glucose-fructose oxidoreductase domain containing 1 6p24.1-p23 1(1/0/0)
GFI1B growth factor independent 1B transcription repressor 9q34.13 1(0/1/0)
GEMIN2 gem (nuclear organelle) associated protein 2 14q21.1 1(1/0/0)
GDNF glial cell derived neurotrophic factor 5p13.1-p12 2(1/1/0)
GABRG1 gamma-aminobutyric acid (GABA) A receptor, gamma 1 4p12 1(0/0/1)
FURIN furin (paired basic amino acid cleaving enzyme) 15q26.1 1(0/0/1)
FTO fat mass and obesity associated 16q12.2 2(1/1/0)
FOXP2 forkhead box P2 7q31 1(1/0/0)
FOXP1 forkhead box P1 3p14.1 1(0/0/1)
FLRT2 fibronectin leucine rich transmembrane protein 2 14q24-q32 1(0/1/0)
FLNC filamin C, gamma 7q32-q35 1(0/0/1)
FHIT fragile histidine triad 3p14.2 1(0/0/1)
FGF12 fibroblast growth factor 12 3q28 1(0/1/0)
FGF10 fibroblast growth factor 10 5p13-p12 1(0/1/0)
FANCL Fanconi anemia, complementation group L 2p16.1 1(0/1/0)
FAIM2 Fas apoptotic inhibitory molecule 2 12q13 1(0/1/0)
FADS2 fatty acid desaturase 2 11q12.2 3(3/0/0)
FADS1 fatty acid desaturase 1 11q12-q13.1 3(1/2/0)
ETV5 ets variant 5 3q28 1(1/0/0)
EREG epiregulin 4q21.21 1(0/0/1)
EMP2 epithelial membrane protein 2 16p13.2 2(0/0/2)
ELOVL6 ELOVL fatty acid elongase 6 4q25 1(0/0/1)
ELK3 ELK3, ETS-domain protein (SRF accessory protein 2) 12q23 2(2/0/0)
DYX1C1 dyslexia susceptibility 1 candidate 1 15q21.1 1(0/1/0)
DUSP1 dual specificity phosphatase 1 5q35.1 1(0/1/0)
DSCC1 DNA replication and sister chromatid cohesion 1 8q24.12 1(0/1/0)
DRD5 dopamine receptor D5 4p16.1 22(14/6/2)
DRD4 dopamine receptor D4 11p15.5 67(49/18/0)
DRD3 dopamine receptor D3 3q13.3 8(1/7/0)
DRD2 dopamine receptor D2 11q22-q23 10(3/7/0)
DRD1 dopamine receptor D1 5q34-q35 8(5/3/0)
DPP6 dipeptidyl-peptidase 6 7q36.2 1(1/0/0)
DPH6 diphthamine biosynthesis 6 15q14 1(0/0/1)
DOCK10 dedicator of cytokinesis 10 2q36.3 1(0/0/1)
DNM1 dynamin 1 9q34 1(0/0/1)
DNAJC27 DnaJ (Hsp40) homolog, subfamily C, member 27 2p23.3 1(1/0/0)
DNAJA1P4 DnaJ (Hsp40) homolog, subfamily A, member 1 pseudogene 4 6q22.1 1(0/1/0)
DMRT2 doublesex and mab-3 related transcription factor 2 9p24.3 1(0/0/1)
DLEU2 deleted in lymphocytic leukemia 2 (non-protein coding) 13q14 1(0/0/1)
DISC1 disrupted in schizophrenia 1 1q42.1 1(1/0/0)
DIRAS2 DIRAS family, GTP-binding RAS-like 2 9q22.32 1(1/0/0)
DHCR7 7-dehydrocholesterol reductase 11q13.4 1(0/0/1)
DGKH diacylglycerol kinase, eta 13q13.3 2(1/1/0)
DENND3 DENN/MADD domain containing 3 8q24.3 1(0/1/0)
DDC dopa decarboxylase (aromatic L-amino acid decarboxylase) 7p12.1 6(5/1/0)
DCLK2 doublecortin-like kinase 2 4q31.3 1(0/0/1)
DCLK1 doublecortin-like kinase 1 13q13.3 1(1/0/0)
DCDC2 doublecortin domain containing 2 6p22.1 1(1/0/0)
DBH dopamine beta-hydroxylase (dopamine beta-monooxygenase) 9q34 21(12/9/0)
DACT1 dishevelled-binding antagonist of beta-catenin 1 14q22.3 1(0/1/0)
CTNNA2 catenin (cadherin-associated protein), alpha 2 2p12-p11.1 2(1/1/0)
CSNK1E casein kinase 1, epsilon 22q13.1 2(1/1/0)
CSMD2 CUB and Sushi multiple domains 2 1p34.3 1(0/0/1)
CRYGC crystallin, gamma C 2q33.3 1(0/0/1)
CREB5 cAMP responsive element binding protein 5 7p15 1(0/0/1)
CPLX4 complexin 4 18q21.32 1(1/0/0)
CPLX2 complexin 2 5q35.2 2(1/0/1)
CPLX1 complexin 1 4p16.3 1(1/0/0)
COX7B2 cytochrome c oxidase subunit VIIb2 4p12 1(0/1/0)
COMT catechol-O-methyltransferase 22q11.21 29(7/22/0)
CNTN5 contactin 5 11q22.1 1(0/0/1)
CNTN4 contactin 4 3p26.3 1(1/0/0)
CNTFR ciliary neurotrophic factor receptor 9p13 1(1/0/0)
CNTF ciliary neurotrophic factor 11q12 1(1/0/0)
CNR1 cannabinoid receptor 1 (brain) 6q14-q15 1(1/0/0)
CMTM8 CKLF-like MARVEL transmembrane domain containing 8 3p22.2 1(1/0/0)
CLYBL citrate lyase beta like 13q32.3 1(0/0/1)
CLOCK clock circadian regulator 4q12 2(2/0/0)
CLASP2 cytoplasmic linker associated protein 2 3p24.3 1(0/0/1)
CHRNA7 cholinergic receptor, nicotinic, alpha 7 (neuronal) 15q13.3 2(0/1/1)
CHRNA4 cholinergic receptor, nicotinic, alpha 4 (neuronal) 20q13.33 7(4/3/0)
CHRNA3 cholinergic receptor, nicotinic, alpha 3 (neuronal) 15q24 1(0/1/0)
CHMP7 charged multivesicular body protein 7 8p21.2 1(0/0/1)
CEP112 centrosomal protein 112kDa 17q24.2 1(0/0/1)
CDK20 cyclin-dependent kinase 20 9q22.1 1(0/1/0)
CDH23 cadherin-related 23 10q22.1 1(0/1/0)
CDH13 cadherin 13 16q23.3 4(1/2/1)
CCSER1 coiled-coil serine-rich protein 1 4q22.1 1(1/0/0)
CAMK1D calcium/calmodulin-dependent protein kinase ID 10p13 1(0/0/1)
CALY calcyon neuron-specific vesicular protein 10q26.3 2(1/1/0)
CADM2 cell adhesion molecule 2 3p12.2 1(1/0/0)
CACNB2 calcium channel, voltage-dependent, beta 2 subunit 10p12 1(1/0/0)
CACNA1C calcium channel, voltage-dependent, L type, alpha 1C subunit 12p13.3 3(0/3/0)
C1orf173 1(0/1/0)
BRE brain and reproductive organ-expressed (TNFRSF1A modulator) 2p23 1(1/0/0)
BMPR1B bone morphogenetic protein receptor, type IB 4q23-q24 1(0/0/1)
BDNF brain-derived neurotrophic factor 11p14.1 16(8/8/0)
BCL11A B-cell CLL/lymphoma 11A (zinc finger protein) 2p16.1 1(0/0/1)
BCHE butyrylcholinesterase 3q26.1-q26.2 1(1/0/0)
BAIAP2 BAI1-associated protein 2 17q25 1(1/0/0)
ATXN2 ataxin 2 12q23-q24.1 1(0/0/1)
ATXN1 ataxin 1 6p23 1(0/0/1)
ATP2C2 ATPase, Ca++ transporting, type 2C, member 2 16q24.1 2(0/1/1)
ATP2B3 ATPase, Ca++ transporting, plasma membrane 3 Xq28 1(0/1/0)
ATP11A ATPase, class VI, type 11A 13q34 1(0/1/0)
ASTN2 astrotactin 2 9q33 2(0/0/2)
ASMT acetylserotonin O-methyltransferase Xp22.3 and Yp11.3 1(1/0/0)
AS3MT arsenic (+3 oxidation state) methyltransferase 10q24.33 1(1/0/0)
ARVCF armadillo repeat gene deleted in velocardiofacial syndrome 22q11.21 1(1/0/0)
ARSB arylsulfatase B 5q14.1 1(0/0/1)
ARRB2 arrestin, beta 2 17p13 1(1/0/0)
ARRB1 arrestin, beta 1 11q13 2(1/1/0)
ANO5 anoctamin 5 11p15.1 1(0/0/1)
ANK3 ankyrin 3, node of Ranvier (ankyrin G) 10q21 2(0/2/0)
AK8 adenylate kinase 8 9q34.13 1(0/0/1)
AK094352 1(0/0/1)
AGBL1 ATP/GTP binding protein-like 1 15q25.3 1(0/0/1)
ADRBK2 adrenergic, beta, receptor kinase 2 22q11 1(0/1/0)
ADRBK1 adrenergic, beta, receptor kinase 1 11q13 1(0/1/0)
ADRB3 adrenoceptor beta 3 8p12 2(0/2/0)
ADRB2 adrenoceptor beta 2, surface 5q31-q32 2(1/1/0)
ADRB1 adrenoceptor beta 1 10q25.3 2(0/2/0)
ADRA2C adrenoceptor alpha 2C 4p16.3 7(2/4/1)
ADRA2B adrenoceptor alpha 2B 2q11.1 1(1/0/0)
ADRA2A adrenoceptor alpha 2A 10q25.2 13(4/9/0)
ADRA1D adrenoceptor alpha 1D 20p13 1(0/1/0)
ADRA1B adrenoceptor alpha 1B 5q33.3 2(1/1/0)
ADRA1A adrenoceptor alpha 1A 8p21.2 3(2/1/0)
AANAT aralkylamine N-acetyltransferase 17q25.1 1(0/0/1)